Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-20-024716

CEO bought 68,000 shares at $0.38 ($25,534)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Woods Lori A CEO 2020-11-30 Purchase +68,000 $0.38 $25,534 610,500 I: show line 1 in the form
Open-market purchases · 68,000 sh · avg $0.38 · $25,534
Loading xslF345X03/rdgdoc.xml…